China Universal Asset Management Co. Ltd. Buys 3,000 Shares of Tenet Healthcare Corporation $THC

China Universal Asset Management Co. Ltd. grew its stake in Tenet Healthcare Corporation (NYSE:THC) by 33.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,000 shares of the company’s stock after acquiring an additional 3,000 shares during the period. China Universal Asset Management Co. Ltd.’s holdings in Tenet Healthcare were worth $2,436,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of THC. William B. Walkup & Associates Inc. bought a new position in Tenet Healthcare in the 3rd quarter worth approximately $32,000. Canada Pension Plan Investment Board bought a new stake in shares of Tenet Healthcare during the second quarter worth $35,000. Westside Investment Management Inc. lifted its stake in shares of Tenet Healthcare by 100.0% during the third quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock valued at $39,000 after acquiring an additional 96 shares during the period. Trust Co. of Vermont acquired a new stake in Tenet Healthcare in the third quarter worth about $41,000. Finally, Caitong International Asset Management Co. Ltd raised its holdings in Tenet Healthcare by 2,227.3% during the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 256 shares of the company’s stock worth $45,000 after purchasing an additional 245 shares during the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

Insider Transactions at Tenet Healthcare

In other Tenet Healthcare news, Director Nadja West sold 2,178 shares of Tenet Healthcare stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $197.47, for a total value of $430,089.66. Following the sale, the director owned 28,480 shares of the company’s stock, valued at $5,623,945.60. This trade represents a 7.10% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 0.81% of the company’s stock.

Tenet Healthcare Trading Down 1.8%

NYSE:THC opened at $227.68 on Friday. The business’s 50-day simple moving average is $201.26 and its 200-day simple moving average is $196.69. Tenet Healthcare Corporation has a fifty-two week low of $109.82 and a fifty-two week high of $235.77. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68. The stock has a market capitalization of $19.80 billion, a PE ratio of 14.70, a price-to-earnings-growth ratio of 1.14 and a beta of 1.44.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, beating analysts’ consensus estimates of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The firm had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. During the same quarter in the previous year, the firm posted $3.44 earnings per share. The business’s revenue was up 8.9% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Sell-side analysts expect that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

THC has been the subject of several analyst reports. KeyCorp lifted their price target on shares of Tenet Healthcare from $225.00 to $250.00 and gave the stock an “overweight” rating in a research report on Thursday, February 12th. Wall Street Zen upgraded shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, January 31st. Barclays raised their price target on Tenet Healthcare from $240.00 to $257.00 and gave the stock an “overweight” rating in a research report on Friday, February 13th. Jefferies Financial Group upped their price objective on Tenet Healthcare from $250.00 to $265.00 and gave the company a “buy” rating in a report on Thursday, February 12th. Finally, TD Cowen restated a “buy” rating on shares of Tenet Healthcare in a report on Thursday, February 12th. One research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, Tenet Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $246.71.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.